doxapram has been researched along with ns 1619 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kikuchi, K; Nakano, H; Ohsaki, Y; Osanai, S; Takahashi, T | 2 |
2 other study(ies) available for doxapram and ns 1619
| Article | Year |
|---|---|
Doxapram stimulates carotid body with different mechanisms from hypoxic chemotransduction.
Topics: Animals; Benzimidazoles; Carotid Body; Chemoreceptor Cells; Doxapram; Electrophysiology; Halothane; Hypoxia; In Vitro Techniques; Male; Nerve Tissue Proteins; Potassium Channels; Potassium Channels, Tandem Pore Domain; Rabbits | 2003 |
Doxapram stimulates the carotid body via a different mechanism than hypoxic chemotransduction.
Topics: Anesthetics, Inhalation; Animals; Benzimidazoles; Carotid Body; Carotid Sinus; Cromakalim; Dose-Response Relationship, Drug; Doxapram; Halothane; Hypoxia; Male; Membrane Potentials; Organ Culture Techniques; Pinacidil; Potassium Channels; Rabbits; Respiratory System Agents; Vasodilator Agents | 2005 |